Atopic DermatitisNCT07142993
Social Media Follow-up Nursing for Atopic Dermatitis
A study testing Social Media-Based Nursing Intervention and Conventional Nursing Care in people with Atopic Dermatitis, run by The First Hospital of Hebei Medical University at 1 site in China.
Trial summary
This is a randomized controlled study to evaluate the effectiveness of a social media-based (WeChat) networked nursing follow-up intervention compared to conventional nursing care for patients with atopic dermatitis. Read more about this study
- Who is it for?
- Ages 20 to 60 years
- Conditions the study is for
- Atopic Dermatitis
- What is being tested?
- Social Media-Based Nursing Intervention and Conventional Nursing Care
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteChina
- Study dates
- 1 May 2022to 1 May 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Aged 20-60 years;
- Diagnosed according to the Williams diagnostic criteria for atopic dermatitis;
- Signed informed consent.
Who cannot join
- Severe, progressive, and uncontrolled major organ or systemic diseases (including cardiovascular, liver, lung, and kidney diseases), other autoimmune diseases, or malignant tumors;
- Pregnant or lactating women;
- Presence of other skin diseases;
- Mental health disorders;
- Previous experience with similar follow-up nursing interventions;
- Severe complications such as infections or allergies.
Trial locations and contacts
1 site in 1 country.
China1 site
the Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000
About this study
Official title: Impact of Social Media-Based Networked Follow-up Nursing Intervention on Itch Severity and Self-care Ability in Patients With Atopic Dermatitis
This is a randomized controlled study to evaluate the effectiveness of a social media-based (WeChat) networked nursing follow-up intervention compared to conventional nursing care for patients with atopic dermatitis. The study aims to determine the impact of the intervention on itch severity, skin condition, and self-care ability over a 6-month period.
Read the detailed description
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that requires long-term management. Traditional outpatient care is often insufficient for managing the chronic nature of the disease. This study explores the effects of social media-based networked follow-up nursing interventions, leveraging popular platforms like WeChat to provide continuous support, personalized care plans, remote monitoring, and health education. This study prospectively enrolled and randomized 100 patients with AD into two groups: a research group receiving the social media-based intervention and a control group receiving conventional nursing care. The primary objective is to compare the differences in itch severity, eczema area and severity index (EASI), overall disease assessment (IGA), and self-care ability between the two groups from baseline to 6 months post-intervention. The study aims to provide evidence for social media-based nursing as an effective adjunctive management strategy for improving outcomes in patients with atopic dermatitis.
- Conditions
- Atopic Dermatitis
- Being tested
- Social Media-Based Nursing Intervention, Conventional Nursing Care
- Medical subject headings
- Dermatitis, Atopic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Social Media-Based Nursing InterventionBehavioural
A structured nursing follow-up program delivered through a WeChat group. The program included regular sharing of educational content (articles, videos), personalized care advice, remote photo-based monitoring by medical staff, and peer support within the group. The intervention was managed by a dedicated team of dermatologists and nurses.
Conventional Nursing CareBehavioural
A standard care follow-up protocol involving verbal education at discharge, provision of printed health materials, and proactive weekly telephone calls to monitor the patient's condition, correct improper self-care actions, and encourage clinic visits if necessary.
| Study group | Role | What they receive |
|---|---|---|
| Experimental: Social Media-Based Nursing Intervention Group | Experimental | Patients (n=50) received networked follow-up nursing intervention via a popular social media platform (WeChat). This included weekly educational materials, daily Q\&A sessions, personalized care plans, remote monitoring of skin condition via photos, continuous health education, and a peer communication group. This intervention was provided as an adjunct to standard medical care. Receives: Behavioral: Social Media-Based Nursing Intervention |
| Active Comparator: Conventional Nursing Care Group | Active comparator | Patients (n=50) received conventional nursing care. This included verbal health education at discharge, distribution of educational materials and a follow-up handbook, and weekly follow-up phone calls from a liaison nurse to assess adherence and provide guidance. This intervention was provided as an adjunct to standard medical care. Receives: Behavioral: Conventional Nursing Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Itch Severity
Measured by the Numeric Rating Scale (NRS) for itching. The scale ranges from 0 (no itching) to 10 (very severe itching), where patients rate the most severe itching experienced in the past 24 hours. A higher score indicates more severe itching.
Measured: Baseline, 6 Months
Change in Self-care Ability
Measured by the Exercise of Self-Care Agency Scale (ESCA). The scale includes 43 items across four dimensions (self-care skills, self-responsibility, self-concept, and health knowledge). It uses a Likert 5-point scoring system (0 to 4 points). A higher total score indicates stronger self-care ability.
Measured: Baseline, 6 Months
Secondary outcomes (2)
Change in Eczema Area and Severity Index (EASI)
EASI is used to evaluate the eczema area and severity. It assesses four clinical signs (erythema, papules/edema, lichenification, epidermal peeling) on a scale of 0 to 3 based on severity. A higher score indicates greater disease severity.
Measured: Baseline, 6 Months
Change in Overall Evaluation Score
Measured by the Investigator's Global Assessment (IGA). A six-level scoring system (0 to 5) is used, where 0 indicates no lesions and 5 indicates very severe disease. A higher score indicates greater overall disease severity.
Measured: Baseline, 6 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Aug 2025
- Study start1 May 2022
- Primary completion1 May 2024
- Study completion1 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Atopic DermatitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- The First Hospital of Hebei Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ruimin Wang, The First Hospital of Hebei Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07142993
- Sponsor's protocol ID
- 2022-S-0038
- Status last verified
- Aug 2025
- First submitted
- 20 Aug 2025
- Last updated
- 27 Aug 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Social Media-Based Networked Follow-up Nursing Intervention on Itch Severity and Self-care Ability in Patients With Atopic Dermatitis
- ClinicalTrials.gov ID
- NCT07142993
- Acronym / sponsor ID
- 2022-S-0038
- Conditions
- Atopic Dermatitis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- The First Hospital of Hebei Medical UniversityUniversity, hospital or other
- Study start
- 1 May 2022 (actual)
- Primary completion
- 1 May 2024 (actual)
- Study completion
- 1 May 2024 (actual)
- First posted
- 27 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a randomized controlled study to evaluate the effectiveness of a social media-based (WeChat) networked nursing follow-up intervention compared to conventional nursing care for patients with atopic dermatitis. The study aims to determine the impact of the intervention on itch severity, skin condition, and self-care ability over a 6-month period.
Detailed description
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that requires long-term management. Traditional outpatient care is often insufficient for managing the chronic nature of the disease. This study explores the effects of social media-based networked follow-up nursing interventions, leveraging popular platforms like WeChat to provide continuous support, personalized care plans, remote monitoring, and health education. This study prospectively enrolled and randomized 100 patients with AD into two groups: a research group receiving the social media-based intervention and a control group receiving conventional nursing care. The primary objective is to compare the differences in itch severity, eczema area and severity index (EASI), overall disease assessment (IGA), and self-care ability between the two groups from baseline to 6 months post-intervention. The study aims to provide evidence for social media-based nursing as an effective adjunctive management strategy for improving outcomes in patients with atopic dermatitis.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental: Social Media-Based Nursing Intervention Group | Experimental | Behavioral: Social Media-Based Nursing InterventionPatients (n=50) received networked follow-up nursing intervention via a popular social media platform (WeChat). This included weekly educational materials, daily Q\&A sessions, personalized care plans, remote monitoring of skin condition via photos, continuous health education, and a peer communication group. This intervention was provided as an adjunct to standard medical care. |
| Active Comparator: Conventional Nursing Care Group | Active comparator | Behavioral: Conventional Nursing CarePatients (n=50) received conventional nursing care. This included verbal health education at discharge, distribution of educational materials and a follow-up handbook, and weekly follow-up phone calls from a liaison nurse to assess adherence and provide guidance. This intervention was provided as an adjunct to standard medical care. |
Who may qualify
- Ages
- 20 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Aged 20-60 years;
- Diagnosed according to the Williams diagnostic criteria for atopic dermatitis;
- Signed informed consent.
Key exclusion criteria (6 listed)
- Severe, progressive, and uncontrolled major organ or systemic diseases (including cardiovascular, liver, lung, and kidney diseases), other autoimmune diseases, or malignant tumors;
- Pregnant or lactating women;
- Presence of other skin diseases;
- Mental health disorders;
- Previous experience with similar follow-up nursing interventions;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Social Media-Based Nursing InterventionA structured nursing follow-up program delivered through a WeChat group. The program included regular sharing of educational content (articles, videos), personalized care advice, remote photo-based monitoring by medical staff, and peer support within the group. The intervention was managed by a dedicated team of dermatologists and nurses. | Behavioural | Experimental: Social Media-Based Nursing Intervention Group |
| Conventional Nursing CareA standard care follow-up protocol involving verbal education at discharge, provision of printed health materials, and proactive weekly telephone calls to monitor the patient's condition, correct improper self-care actions, and encourage clinic visits if necessary. | Behavioural | Active Comparator: Conventional Nursing Care Group |
Primary outcome
Change in Itch Severity
Time frame: Baseline, 6 Months
Measured by the Numeric Rating Scale (NRS) for itching. The scale ranges from 0 (no itching) to 10 (very severe itching), where patients rate the most severe itching experienced in the past 24 hours. A higher score indicates more severe itching.
Change in Self-care Ability
Time frame: Baseline, 6 Months
Measured by the Exercise of Self-Care Agency Scale (ESCA). The scale includes 43 items across four dimensions (self-care skills, self-responsibility, self-concept, and health knowledge). It uses a Likert 5-point scoring system (0 to 4 points). A higher total score indicates stronger self-care ability.
2 secondary outcomes
Change in Eczema Area and Severity Index (EASI)
Time frame: Baseline, 6 Months
Change in Overall Evaluation Score
Time frame: Baseline, 6 Months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Aug 2025.
Related trials for Atopic Dermatitis
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
RecruitingObservational study
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Cutaneous T-cell Lymphoma, Sezary Syndrome
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Not yet recruitingPhase 1
A Study of HSK60002 Tablets in Participants With Moderate-to-Severe Atopic Dermatitis
Dermatitis Atopic
RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Social Media-Based Nursing Intervention and Conventional Nursing Care in people with Atopic Dermatitis, run by The First Hospital of Hebei Medical University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Itch Severity (time frame: Baseline, 6 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2025.